The most prominent among them tracked medical and prescription records of over 10,000 patients with early-stage cancer, and found GLP-1s reduced cancer risk in 6 out of 7 cancers four of them at statistically significant levels
She did a follow up to ensure about the situation
Hall RA, Bates S, Lenardon MD, Maccallum DM, Wagener J, Lowman DW, et al
Finally, two sweeping pieces of US legislation are impacting the industry: 2022s Inflation Reduction Act (IRA) and the Biosecure Act, which has (as of mid-December) still to pass
Clinical trial in adolescents: A recent clinical trial showed that teens who were overweight or obese also lost weight on semaglutide